Skip to main content
FNCHQ logo

FNCHQ · Finch Therapeutics Group, Inc. · Shareholders & Ownership

Track FNCHQ — free
$10.35 At close · Sep 23
Market Cap
$16.62M
Shares
1.61M
Volume · Sep 23 5800 Avg daily vol (3M) 2195

Every disclosed holder of FNCHQ in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.

Who Owns FNCHQ

13F quarter Jun 30, 2024
Holder group Shares % Out
Institutional (13F) 21,206 1.32%
Insiders (Forms 3, 4, 5) 0 0.00%
13D/G-only blocks 0 0.00%
Remaining 1,584,557 98.68%
Registered funds (N-PORT, not summed) 1 0.00%

Shares outstanding: 1,605,763, the issuer's latest cover-page count restated onto today's split basis.

13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.

Holders of FNCHQ

# Holder Shares
1
LAKE STREET ADVISORS GROUP, LLC
13F CIK 1724269 · Unknown · Jun 30, 2024
21,206
2
Guggenheim Active Allocation Fund
Fund · Registered fund · Aug 31, 2026
Guggenheim Active Allocation Fund, not summed
1

Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.

Key facts CIK 1733257 CUSIP 31773D200 Visit website